Who Owns Larimar Therapeutics Stock?
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 2.67 0.00%
Ownership breakdown
- Held by institutions
- 93.42%
- Held by insiders
- 1.19%
- Institutional holders
- 214
- Institutions 93.4%
- Insiders 1.2%
- Public and other 5.4%
Who owns Larimar Therapeutics stock?
Institutional investors own about 93.4% of Larimar Therapeutics's shares, spread across 214 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.19% of LRMR.
The largest institutional holders are Deerfield Management Company, L.P (34.28%), Blue Owl Capital Holdings LP (8.82%) and Blackrock Inc. (5.47%). Together, the top 10 institutions control 66.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their LRMR positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LRMR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Deerfield Management Company, L.P | 35.61M | 34.28% | 0.0% |
| Blue Owl Capital Holdings LP | 9.16M | 8.82% | +28.7% |
| Blackrock Inc. | 5.68M | 5.47% | +51.3% |
| Defilade Capital Management, L.P. | 3.67M | 3.53% | +100.0% |
| Driehaus Capital Management, LLC | 3.16M | 3.05% | +7.8% |
| Vanguard Capital Management LLC | 2.97M | 2.86% | +3.8% |
| RTW Investments LP | 2.57M | 2.47% | +71.1% |
| AQR Capital Management, LLC | 2.37M | 2.28% | +190.1% |
| Marshall Wace LLP | 2.01M | 1.94% | +115.6% |
| DAFNA Capital Management, LLC | 2.01M | 1.93% | -1.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LRMR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.21M | 2.12% |
| iShares Trust-iShares Russell 2000 ETF | 1.70M | 1.64% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 937.22K | 0.90% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 757.60K | 0.73% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 726.52K | 0.70% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 699.47K | 0.67% |
| Vanguard Explorer Fund | 659.13K | 0.63% |
| iShares Trust-iShares Russell 2000 Growth ETF | 629.94K | 0.61% |
| iShares Trust-iShares Biotechnology ETF | 391.47K | 0.38% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 340.79K | 0.33% |
Frequently asked questions
Who is the largest shareholder of Larimar Therapeutics?
Deerfield Management Company, L.P is the largest institutional shareholder of LRMR, owning 34.28% of shares outstanding (35.61M shares) as of its latest 13F filing.
What percentage of Larimar Therapeutics is owned by institutions?
Institutions own about 93.4% of LRMR shares and 94.5% of the public float.
How much of Larimar Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.19% of LRMR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.